首页> 外国专利> New hybridoma Han-41 and its corresp. antibody - recognise glyco-protein found in broncho-alveolar system; useful as cell differentiation markers and to classify human lung

New hybridoma Han-41 and its corresp. antibody - recognise glyco-protein found in broncho-alveolar system; useful as cell differentiation markers and to classify human lung

机译:新型杂交瘤汉41及其对应。抗体-识别支气管肺泡系统中发现的糖蛋白;可用作细胞分化标记并分类人肺

摘要

The hybridoma cell line Han-41 (DSM ACC2002) is new. It is made by fusing spleen cells, taken from a mouse which has been immunised with an immunogen from an epithelial cell line (HFBE) from the bronchus of a human female foetus in the 18th week of gestation with myeloma cells. Also new are monoclonal antibodies SEC-41 (IgG1, kappa; recognising a glycoprotein of mol.wt. about 52000) produced (as sole antibody) by this cell line. USE/ADVANTAGE - SEC-41 is useful (1) as a differentiation marker for secretary cells in adult human bronchial epithelium; (2) as a marker for development of Clara and type II pneumocytes in human foetal lungs and (3) as diagnostic marker for sub-typing human pulmonary adenocarcinoma
机译:杂交瘤细胞系Han-41(DSM ACC2002)是新的。它是通过将脾脏细胞融合而制成的,小鼠的脾脏细胞在妊娠第18周时已被人类女性胎儿的支气管上皮细胞系(HFBE)的免疫原免疫了免疫。由该细胞系产生的单克隆抗体SEC-41(IgG1,κ;识别分子量约52000的糖蛋白)(作为唯一抗体)也是新的。使用/优势-SEC-41有用(1)作为成人支气管上皮中秘书细胞的分化标记; (2)作为人类胎肺中Clara和II型肺细胞发育的标志物,以及(3)作为人类肺腺癌亚型分型的诊断标志物

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号